Prostate cancer Board decisions

The Veteran's service-connected disabilities have precluded him from securing and following substantially gainful employment during the period on appeal, warranting a grant of TDIU.

The Board has remanded the Veteran's appeal for a new VA prostate examination to assess his current disability due to service-connected prostate cancer status post brachytherapy, including any renal dysfunction.

The Board has decided to remand the case due to insufficient opinions regarding the relationship between the Veteran's hepatocellular cancer and service, as well as the role of his prostate cancer in causing death. The VA will need to obtain additional medical opinions.

The Board denied compensation benefits under 38 U.S.C. § 1151 for prostate cancer and its residuals, finding that VA did not fail to diagnose or treat the Veteran's condition in a timely manner.

The Board has determined that there was a claims processing error and the Veteran's appeal should have been handled under the legacy system. The matter is now remanded for the issuance of an SOC addressing the issue on appeal, which includes whether new and material evidence has been received to reopen the claim of entitlement to service connection for prostate cancer.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence linking his current condition to his military service.

The Board has remanded the claims for service connection for prostate cancer, bladder disability, erectile dysfunction, and scars due to new evidence being added to the record.

The Board has remanded the claims of service connection for prostate cancer and erectile dysfunction due to incomplete development. The Veteran's prostate cancer may be related to active military service, but a VA examination is needed to determine this. Service connection for erectile dysfunction would also be inextricably intertwined with prostate cancer.

The Veteran's prostate cancer is presumed to be related to herbicide agent exposure during his active service, and the Board has granted service connection for this condition.

The Veteran's PTSD symptoms did not result in total occupational and social impairment, resulting in a denial of a rating in excess of 70 percent. From May 16, 2019 to October 1, 2021, the issue of TDIU was moot as he had a maximum schedular rating (100%). From October 1, 2021 onwards, TDIU was denied.

The Board has remanded the cases due to insufficient evidence regarding the Veteran's exposure to herbicide agents at Fort Drum, which is necessary for establishing service connection for diabetes mellitus type II and prostate cancer.

The Veteran's prostate cancer is granted service connection based on in-service herbicide exposure.,The Veteran's bilateral interstitial fibrosis claim is remanded for further examination and opinion regarding the relationship to service.

The Board has remanded the claims for service connection for prostate cancer and erectile dysfunction as secondary to prostate cancer due to potential exposure to Agent Orange during military service. The PACT Act requires a VA examination if there is evidence of participation in a toxic exposure risk activity (TERA).

The Veteran's obesity claim is denied as it is not a disease or disability for VA compensation purposes.,Hypertension, prostatectomy residuals (claimed as prostate cancer), left knee disability, right knee disability, and obstructive sleep apnea are all remanded for further evaluation.

The Board has decided to remand the claims for service connection due to insufficient medical records and the need to obtain additional information from private healthcare providers. The Veteran served at Camp Lejeune, North Carolina during his military service.

The Veteran's prostate cancer is denied as there was no in-service exposure to Agent Orange and the evidence does not support a direct link between service and his current condition.

Service connection for ischemic heart condition and residuals of prostate cancer is granted pursuant to the PACT Act, effective August 10, 2022. Service connection for Parkinson's disease and Lewy body dementia is remanded.

The Board has denied the Veteran's claims for service connection for a bilateral shoulder disability, prostate cancer, diabetes mellitus type II (DM), and diabetic neuropathy of the bilateral upper and lower extremities. The TDIU claim is also remanded.

The Veteran's diabetes mellitus, type II, is rated at 20 percent and denied a higher rating.,The Veteran's prostate cancer residuals are rated at 40 percent from October 20, 2015 to December 29, 2020, and higher than 40 percent thereafter. A compensable rating for erectile dysfunction is also denied.

The Board denied service connection for cause of death, finding that the Veteran's service-connected conditions did not contribute to his death. The Board noted that liver failure was caused by reactivation of hepatitis B due to medications used for non-service-connected rheumatic arthritis.